Dexcom (DC4) Ratios
Dexcom Ratios
DE:DC4's free cash flow for Q3 2026 was $272.70M. For the 2026 fiscal year, DE:DC4's free cash flow was decreased by $-52.90M and operating cash flow was $325.60M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.88 | 1.47 | 2.84 | 1.99 | 5.11 |
| Quick Ratio | 1.59 | 1.28 | 2.48 | 1.83 | 4.62 |
| Cash Ratio | 0.43 | 0.21 | 0.36 | 0.35 | 1.46 |
| Solvency Ratio | 0.30 | 0.18 | 0.17 | 0.15 | 0.11 |
| Operating Cash Flow Ratio | 0.67 | 0.34 | 0.48 | 0.36 | 0.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.82 | 0.00 | 0.87 | 0.00 |
| Net Current Asset Value | $ 439.40M | $ -80.50M | $ 230.00M | $ 408.90M | $ 793.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.40 | 0.41 | 0.40 | 0.44 |
| Debt-to-Equity Ratio | 0.51 | 1.23 | 1.25 | 1.01 | 1.06 |
| Debt-to-Capital Ratio | 0.34 | 0.55 | 0.56 | 0.50 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.37 | 0.54 | 0.36 | 0.49 |
| Financial Leverage Ratio | 2.31 | 3.08 | 3.03 | 2.53 | 2.42 |
| Debt Service Coverage Ratio | 60.46 | 0.66 | 36.84 | 0.65 | 17.96 |
| Interest Coverage Ratio | 49.83 | 31.58 | 29.44 | 21.03 | 14.14 |
| Debt to Market Cap | 0.05 | 0.08 | 0.05 | 0.04 | 0.04 |
| Interest Debt Per Share | 3.61 | 6.44 | 6.77 | 5.56 | 5.63 |
| Net Debt to EBITDA | 0.35 | 2.10 | 2.21 | 2.66 | 2.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.10% | 60.46% | 63.19% | 64.72% | 68.63% |
| EBIT Margin | 23.74% | 18.05% | 20.17% | 14.07% | 11.26% |
| EBITDA Margin | 29.14% | 23.45% | 25.31% | 19.43% | 15.42% |
| Operating Profit Margin | 19.56% | 14.88% | 16.50% | 13.44% | 10.86% |
| Pretax Profit Margin | 23.35% | 17.58% | 19.61% | 13.43% | 10.49% |
| Net Profit Margin | 17.94% | 14.29% | 14.95% | 11.73% | 8.86% |
| Continuous Operations Profit Margin | 17.94% | 14.29% | 14.95% | 11.73% | 8.86% |
| Net Income Per EBT | 76.84% | 81.27% | 76.22% | 87.31% | 84.46% |
| EBT Per EBIT | 119.37% | 118.17% | 118.86% | 99.90% | 96.61% |
| Return on Assets (ROA) | 13.19% | 8.89% | 8.64% | 6.33% | 4.40% |
| Return on Equity (ROE) | 30.46% | 27.40% | 26.18% | 16.01% | 10.62% |
| Return on Capital Employed (ROCE) | 21.72% | 16.89% | 12.69% | 11.01% | 6.31% |
| Return on Invested Capital (ROIC) | 16.61% | 10.20% | 9.63% | 7.86% | 5.30% |
| Return on Tangible Assets | 13.39% | 9.06% | 8.87% | 6.57% | 4.45% |
| Earnings Yield | 3.23% | 1.83% | 1.13% | 0.77% | 0.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.61 | 3.90 | 3.67 | 3.87 | 4.74 |
| Payables Turnover | 5.40 | 4.62 | 4.82 | 4.32 | 4.05 |
| Inventory Turnover | 2.96 | 2.94 | 2.38 | 3.35 | 2.15 |
| Fixed Asset Turnover | 2.85 | 2.88 | 3.06 | 2.56 | 2.75 |
| Asset Turnover | 0.74 | 0.62 | 0.58 | 0.54 | 0.50 |
| Working Capital Turnover Ratio | 2.86 | 1.90 | 1.54 | 1.21 | 0.85 |
| Cash Conversion Cycle | 156.87 | 138.70 | 177.03 | 118.81 | 156.81 |
| Days of Sales Outstanding | 100.99 | 93.54 | 99.51 | 94.35 | 77.01 |
| Days of Inventory Outstanding | 123.45 | 124.18 | 153.18 | 109.03 | 169.81 |
| Days of Payables Outstanding | 67.56 | 79.03 | 75.66 | 84.58 | 90.01 |
| Operating Cycle | 224.44 | 217.73 | 252.69 | 203.39 | 246.82 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.69 | 2.45 | 1.94 | 1.72 | 1.14 |
| Free Cash Flow Per Share | 2.76 | 1.56 | 1.33 | 0.78 | 0.14 |
| Dividend Paid and CapEx Coverage Ratio | 3.96 | 2.76 | 3.16 | 1.84 | 1.14 |
| Capital Expenditure Coverage Ratio | 3.96 | 2.76 | 3.16 | 1.84 | 1.14 |
| Operating Cash Flow Coverage Ratio | 1.04 | 0.38 | 0.29 | 0.31 | 0.21 |
| Operating Cash Flow to Sales Ratio | 0.31 | 0.25 | 0.21 | 0.23 | 0.18 |
| Free Cash Flow Yield | 4.16% | 2.00% | 1.07% | 0.69% | 0.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.01 | 54.61 | 88.46 | 129.24 | 239.45 |
| Price-to-Sales (P/S) Ratio | 5.56 | 7.80 | 13.22 | 15.15 | 21.21 |
| Price-to-Book (P/B) Ratio | 9.43 | 14.97 | 23.16 | 20.68 | 25.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.04 | 49.89 | 93.57 | 144.72 | 974.44 |
| Price-to-Operating Cash Flow Ratio | 17.98 | 31.80 | 63.99 | 65.86 | 117.37 |
| Price-to-Earnings Growth (PEG) Ratio | 0.67 | 39.32 | 1.39 | 2.26 | -4.18 |
| Enterprise Value Multiple | 19.41 | 35.37 | 54.46 | 80.66 | 140.51 |
| Enterprise Value | 26.37B | 33.45B | 49.93B | 45.60B | 53.04B |
| EV to EBITDA | 19.41 | 35.37 | 54.46 | 80.66 | 140.51 |
| EV to Sales | 5.66 | 8.29 | 13.78 | 15.67 | 21.66 |
| EV to Free Cash Flow | 24.48 | 53.03 | 97.53 | 149.65 | 995.17 |
| EV to Operating Cash Flow | 18.30 | 33.80 | 66.70 | 68.11 | 119.87 |
| Tangible Book Value Per Share | 6.79 | 4.88 | 4.95 | 4.96 | 5.13 |
| Shareholders’ Equity Per Share | 7.04 | 5.20 | 5.36 | 5.47 | 5.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.19 | 0.24 | 0.13 | 0.16 |
| Revenue Per Share | 11.95 | 9.97 | 9.38 | 7.47 | 6.33 |
| Net Income Per Share | 2.14 | 1.42 | 1.40 | 0.88 | 0.56 |
| Tax Burden | 0.77 | 0.81 | 0.76 | 0.87 | 0.84 |
| Interest Burden | 0.98 | 0.97 | 0.97 | 0.95 | 0.93 |
| Research & Development to Revenue | 0.13 | 0.14 | 0.14 | 0.17 | 0.25 |
| SG&A to Revenue | 0.28 | 0.32 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 |
| Income Quality | 1.72 | 1.72 | 1.38 | 1.96 | 2.86 |
Currency in USD